PAREXEL Shapes the Real-World Data Revolution

PAREXEL convened industry experts to discuss how real-world data trials and early payer engagement can improve likelihood of launch and market access. The roundtable discussion was influenced by The Innovation Imperative: The Future of Drug Development, an Economist Intelligence Unit report commissioned by PAREXEL.

Read the Full Article

Premium Content

  • Video Highlights
  • PAREXEL Insights
  • News & Events
  • Highlights
Inside PAREXEL:
How PAREXEL leverages data to make better, more informed decisions
Inside PAREXEL:
Leveraging insights from real world data
Simplifying Data
Analytics and Insights with PAREXEL
Simplifying Clinical Trial Design and Execution
with PAREXEL®
Inside PAREXEL:
Genomic Medicine
Inside PAREXEL:
Protocol Optimization
Utilizing Secondary Data Assets
PAREXEL® Access
Navigating Regulatory Submissions
PAREXEL® Consulting
Increasing Study Predictability
PAREXEL® Clinical Development Optimization
Nothing is Bigger than Your Molecule
PAREXEL® Clinical Research Services
Beginning with the End in Mind
PAREXEL® Clinical, Regulatory and Commercial Consulting
Using Technology to Bring it All Together
PAREXEL® Clinical Trials Technology
PAREXEL's Alberto Grignolo, PhD
Comments on Key Trends at DIA 2015
CONCEPT TO COMMERCIALIZATION
Solving the Complex
More Videos

February 27, 2019
Endpoints News: PAREXEL recruits top FDA oncology expert Amy McKee for new R&D initiative

Read more

February 19th, 2018
Drug Discovery News: Biotech Boost: Dedicated PAREXEL Division Helps Emerging Companies

Read more

January 7th, 2019
In Vivo: The Evolving Dynamics of Patient Access and Its Impact

Read more

Browse by Topic

  • Biotech Business Trends
  • Data Analytics and Insights
  • Global Drug Development
  • Regulatory and Market Access
  • Talent Management
  • Technology Solutions
  • Workplace and Culture

View All PAREXEL Insights

Latest Insights